Fintan Keegan
2013
In 2013, Fintan Keegan earned a total compensation of $2.1M as Executive Vice President, Technical Operations at Jazz Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $260,000 |
|---|---|
| Option Awards | $695,750 |
| Salary | $356,667 |
| Stock Awards | $739,125 |
| Other | $27,300 |
| Total | $2,078,842 |
Keegan received $739.1K in stock awards, accounting for 36% of the total pay in 2013.
Keegan also received $260K in non-equity incentive plan, $695.8K in option awards, $356.7K in salary and $27.3K in other compensation.
Rankings
In 2013, Fintan Keegan's compensation ranked 3,787th out of 12,286 executives tracked by ExecPay. In other words, Keegan earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,787 out of 12,286 | 69th |
Division Manufacturing | 1,285 out of 4,612 | 72nd |
Major group Chemicals And Allied Products | 346 out of 1,462 | 76th |
Industry group Drugs | 241 out of 1,156 | 79th |
Industry Pharmaceutical Preparations | 197 out of 890 | 78th |
Source: SEC filing on June 12, 2014.
Keegan's colleagues
We found four more compensation records of executives who worked with Fintan Keegan at Jazz Pharmaceuticals in 2013.